Bohn Scott R 4

What Happened Scott R. Bohn, Chief Development Officer and Head of Lab at Healthpeak Properties (DOC), reported selling 10,989 shares on May 12, 2026. The shares were disposed of in multiple transactions at a weighted average price of $19.45 per share for total proceeds of approximately $213,740. This was a sale (not a purchase or award), which is often routine insider selling rather than a direct signal of company prospects.

Key Details

• Transaction date: May 12, 2026; Form 4 filed May 13, 2026 (next day).
• Transaction type/code: Sale (S) — open-market sales in multiple trades.
• Prices: Weighted average $19.45; individual trade prices ranged from $19.4250 to $19.4950 (footnote).
• Proceeds: Approximately $213,740.
• Shares owned after transaction: Not disclosed in the filing.
• Notable footnote: The reported price is a weighted average; the filer offers to provide a breakdown of the number of shares sold at each separate price on request to the issuer, any shareholder, or the SEC staff.
• Filing timeliness: Filed the day after the transactions; appears to be within the normal SEC reporting window for insiders.

Context

• Sales by insiders can be for many personal or tax reasons and do not by themselves prove a change in company fundamentals. Purchases are generally considered a stronger positive signal than sales.
• This filing reports direct share disposals only; no options exercise, award, gift, or withholding was reported.